Basic information Safety Related Supplier
  • Levalbuterol Related Compound E (30 mg) (alpha-[{(1,1-Dimethylethyl)amino}methyl]-3-(ethoxy-methyl)-4-hydroxy-benzenemethanol)
  • Levalbuterol Related Compound E (30 mg) (alpha-[{(1,1-Dimethylethyl)amino}methyl]-3-(ethoxy-methyl)-4-hydroxy-benzenemethanol)
  • Levalbuterol Related Compound E (30 mg) (alpha-[{(1,1-Dimethylethyl)amino}methyl]-3-(ethoxy-methyl)-4-hydroxy-benzenemethanol)
  • Levalbuterol Related Compound E (30 mg) (alpha-[{(1,1-Dimethylethyl)amino}methyl]-3-(ethoxy-methyl)-4-hydroxy-benzenemethanol)
  • Levalbuterol Related Compound E (30 mg) (alpha-[{(1,1-Dimethylethyl)amino}methyl]-3-(ethoxy-methyl)-4-hydroxy-benzenemethanol)

1/5

Levalbuterol Related Compound E (30 mg) (alpha-[{(1,1-Dimethylethyl)amino}methyl]-3-(ethoxy-methyl)-4-hydroxy-benzenemethanol) NEW

Get Latest Price
  • Min. Order1KG
  • Purity99%
  • Cas No754926-25-5
  • Supply Ability50000KG/month
  • Update time2024-11-01
Hebei Mojin Biotechnology Co., Ltd
Hebei Mojin Biotechnology Co., Ltd
5YR JapanJapan
Chemical Properties
Product Name Levalbuterol Related Compound E (30 mg) (alpha-[{(1,1-Dimethylethyl)amino}methyl]-3-(ethoxy-methyl)-4-hydroxy-benzenemethanol)
CAS No 754926-25-5
EC-No
Min. Order 1KG
Purity 99%
Supply Ability 50000KG/month
Release date 2024/11/01

Company Profile Introduction

Recommended supplier